Advertisement

Topics

BioLife Solutions, Inc. Executes Supply Agreement With Celyad For CryoStor Use In Natural Killer Receptor Based T-Cell (NKR-T) Platform Targeting Solid Tumors And Blood Cancers

20:00 EDT 30 Jul 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: BioLife Solutions, Inc. Executes Supply Agreement With Celyad For CryoStor Use In Natural Killer Receptor Based T-Cell (NKR-T) Platform Targeting Solid Tumors And Blood Cancers

NEXT ARTICLE

More From BioPortfolio on "BioLife Solutions, Inc. Executes Supply Agreement With Celyad For CryoStor Use In Natural Killer Receptor Based T-Cell (NKR-T) Platform Targeting Solid Tumors And Blood Cancers"

Quick Search
Advertisement